Sensus Healthcare Yönetim
Yönetim kriter kontrolleri 4/4
Sensus Healthcare CEO'su Joe Sardano, Jun2010 tarihinde atandı, in görev süresi 14.42 yıldır. in toplam yıllık tazminatı $ 687.60K olup, şirket hissesi ve opsiyonları dahil olmak üzere 65.4% maaş ve 34.6% ikramiyelerden oluşmaktadır. şirketin hisselerinin 7.17% ine doğrudan sahiptir ve bu hisseler $ 10.51M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.3 yıl ve 7.8 yıldır.
Anahtar bilgiler
Joe Sardano
İcra Kurulu Başkanı
US$687.6k
Toplam tazminat
| CEO maaş yüzdesi | 65.4% |
| CEO görev süresi | 14.4yrs |
| CEO sahipliği | 7.2% |
| Yönetim ortalama görev süresi | 3.3yrs |
| Yönetim Kurulu ortalama görev süresi | 7.8yrs |
Son yönetim güncellemeleri
Recent updates
Results: Sensus Healthcare, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 19
Sensus Healthcare, Inc. (NASDAQ:SRTS) Doing What It Can To Lift Shares
Nov 12At US$6.10, Is It Time To Put Sensus Healthcare, Inc. (NASDAQ:SRTS) On Your Watch List?
Oct 03Returns At Sensus Healthcare (NASDAQ:SRTS) Are On The Way Up
May 12Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk
Apr 16Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 11There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital
Oct 17Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger
Jul 04Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop
Mar 14Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?
Mar 06Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger
Oct 11Sensus Healthcare Q2 GAAP EPS, revenue beats
Aug 04Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month
May 21Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts
May 11Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist
Apr 29Sensus Healthcare's (NASDAQ:SRTS) Earnings Are Of Questionable Quality
Apr 01Are Investors Undervaluing Sensus Healthcare, Inc. (NASDAQ:SRTS) By 31%?
Dec 17CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$9m |
| Jun 30 2024 | n/a | n/a | US$7m |
| Mar 31 2024 | n/a | n/a | US$5m |
| Dec 31 2023 | US$688k | US$450k | US$485k |
| Sep 30 2023 | n/a | n/a | -US$896k |
| Jun 30 2023 | n/a | n/a | US$2m |
| Mar 31 2023 | n/a | n/a | US$6m |
| Dec 31 2022 | US$754k | US$400k | US$24m |
| Sep 30 2022 | n/a | n/a | US$27m |
| Jun 30 2022 | n/a | n/a | US$25m |
| Mar 31 2022 | n/a | n/a | US$21m |
| Dec 31 2021 | US$628k | US$375k | US$4m |
| Sep 30 2021 | n/a | n/a | -US$181k |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$4m |
| Dec 31 2020 | US$510k | US$375k | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$7m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | n/a | n/a | -US$3m |
| Dec 31 2019 | US$467k | US$375k | -US$2m |
| Sep 30 2019 | n/a | n/a | -US$3m |
| Jun 30 2019 | n/a | n/a | -US$2m |
| Mar 31 2019 | n/a | n/a | -US$3m |
| Dec 31 2018 | US$538k | US$360k | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$3m |
| Jun 30 2018 | n/a | n/a | -US$3m |
| Mar 31 2018 | n/a | n/a | -US$3m |
| Dec 31 2017 | US$490k | US$324k | -US$4m |
Tazminat ve Piyasa: Joe 'ın toplam tazminatı ($USD 687.60K ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 652.28K ).
Tazminat ve Kazançlar: Joe 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Joe Sardano (71 yo)
14.4yrs
Görev süresi
US$687,599
Tazminat
Mr. Joseph C. Sardano, also known as Joe, serves as Director at BioFlorida Inc since August 2021. He Co-Founded Sensus Healthcare, Inc. in 2010 and has been its Chairman of the Board, Chief Executive Offic...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder | 14.4yrs | US$687.60k | 7.17% $ 10.5m | |
| President | 7.8yrs | US$452.53k | 0.46% $ 669.1k | |
| Chief Financial Officer | 4.8yrs | US$357.06k | 0.25% $ 359.8k | |
| Chief Operating Officer | 1.8yrs | Veri yok | 0.060% $ 87.3k | |
| Chief Technology Officer | 1.8yrs | Veri yok | 0.061% $ 89.4k | |
| Vice President of Marketing | 1.8yrs | Veri yok | Veri yok |
3.3yrs
Ortalama Görev Süresi
46yo
Ortalama Yaş
Deneyimli Yönetim: SRTS 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.3 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder | 14.4yrs | US$687.60k | 7.17% $ 10.5m | |
| President | less than a year | US$452.53k | 0.46% $ 669.1k | |
| Independent Director | 8.3yrs | US$75.00k | 0.28% $ 415.4k | |
| Member of Medical Advisory Board | 7.8yrs | Veri yok | Veri yok | |
| Member of Medical Advisory Board | no data | Veri yok | Veri yok | |
| Member of Medical Advisory Board | 7.8yrs | Veri yok | Veri yok | |
| Member of Medical Advisory Board | 7.8yrs | Veri yok | Veri yok | |
| Independent Director | 9.1yrs | US$75.00k | 0.061% $ 89.4k | |
| Member of Medical Advisory Board | no data | Veri yok | Veri yok | |
| Member of Medical Advisory Board | 7yrs | Veri yok | Veri yok | |
| Member of the Medical Advisory Board | no data | Veri yok | Veri yok | |
| Member of Medical Advisory Board | no data | Veri yok | Veri yok |
7.8yrs
Ortalama Görev Süresi
71yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: SRTS 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.8 yıldır).